Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3687485015 | Product containing metformin and sitagliptin in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3687486019 | Metformin and sitagliptin in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3687487011 | Product containing metformin and sitagliptin in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710792017 | Product containing metformin and sitagliptin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710793010 | Metformin- and sitagliptin-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | est un(e) (attribut) | Product containing sitagliptin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | a pour principe actif (attribut) | Sitagliptin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | est un(e) (attribut) | Product containing metformin and sitagliptin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | est un(e) (attribut) | Metformin-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | a pour principe actif (attribut) | Metformin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only metformin and sitagliptin in oral dose form (medicinal product form) | est un(e) (attribut) | True | Product containing metformin and sitagliptin in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | False | Product containing metformin and sitagliptin in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet | est un(e) (attribut) | False | Product containing metformin and sitagliptin in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR